Literature DB >> 9261345

Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells.

J Stone-Hulslander1, T G Morrison.   

Abstract

For many paramyxoviruses, including Newcastle disease virus (NDV), syncytium formation requires the expression of both surface glycoproteins (HN and F) in the same cell, and evidence suggests that fusion involves a specific interaction between the HN and F proteins. Because a potential interaction in paramyxovirus-infected cells has never been demonstrated, such as interaction was explored by using coimmunoprecipitation and cross-linking. Both HN and F proteins could be precipitated with heterologous antisera after a 5-min radioactive pulse as well as after a 2-h chase in nonradioactive medium, but at low levels. Chemical cross-linking increased detection of complexes containing HN and F proteins at the cell surface. After cross-linking, intermediate- as well as high-molecular-weight species containing both proteins were precipitated with monospecific antisera. Precipitation of proteins with anti-HN after cross-linking resulted in the detection of complexes which electrophresed in the stacker region of the gel, from 160 to 300 kDa, at 150 kDa, and at 74 kDa. Precipitates obtained with anti-F after cross-linking contained species which migrated in the stacker region of the gel, between 160 and 300 kDa, at 120 kDa, and at 66 kDa. The three to four discrete complexes ranging in size from 160 to 300 kDa contained both HN and F proteins when precipitated with either HN or F antisera. That cross-linking of complexes containing both HN and F proteins was not simply a function of overexpression of viral glycoproteins at the cell surface was addressed by demonstrating cross-linking at early time points postinfection, when levels of viral surface glycoproteins are low. Use of cells infected with an avirulent strain of NDV showed that chemically cross-linked HN and F proteins were precipitated independent of cleavage of F0. Furthermore, under conditions that maximized HN protein binding to its receptor, there was no change in the percentages of HN and F0 proteins precipitated with heterologous antisera, but a decrease in F1 protein precipitated was observed upon attachment. These data argue that the HN and F proteins interact in the rough endoplasmic reticulum. Upon attachment of the HN protein to its receptor, the HN protein undergoes a conformational change which causes a conformational change in the associated F protein, releasing the hydrophobic fusion peptide into the target membrane and initiating fusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261345      PMCID: PMC191901     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Protein metabolism during the steady state of Newcastle disease virus infection. I. Kinetics of amino acid and protein accumulation.

Authors:  L E Hightower; M A Bratt
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  The use of circular dichroism to study conformational changes induced in Sendai virus envelope glycoproteins. A correlation with the viral fusogenic activity.

Authors:  V Citovsky; P Yanai; A Loyter
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

3.  Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region.

Authors:  M Hsu; A Scheid; P W Choppin
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

4.  Intracellular processing of the Newcastle disease virus fusion glycoprotein.

Authors:  T Morrison; L J Ward; A Semerjian
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking.

Authors:  M A Markwell; C F Fox
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

6.  Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum.

Authors:  Y Tanaka; B R Heminway; M S Galinski
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.

Authors:  Q Yao; X Hu; R W Compans
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Intracellular processing of the vesicular stomatitis virus glycoprotein and the Newcastle disease virus hemagglutinin-neuraminidase glycoprotein.

Authors:  T G Morrison; L J Ward
Journal:  Virus Res       Date:  1984       Impact factor: 3.303

9.  N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers.

Authors:  J V Staros
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

10.  Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus.

Authors:  T Toyoda; T Sakaguchi; K Imai; N M Inocencio; B Gotoh; M Hamaguchi; Y Nagai
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

View more
  52 in total

1.  Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.

Authors:  Toru Takimoto; Garry L Taylor; Helen C Connaris; Susan J Crennell; Allen Portner
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Type II integral membrane protein, TM of J paramyxovirus promotes cell-to-cell fusion.

Authors:  Zhuo Li; Cher Hung; Reay G Paterson; Frank Michel; Sandra Fuentes; Ryan Place; Yuan Lin; Robert J Hogan; Robert A Lamb; Biao He
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

4.  Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.

Authors:  Tatiana Bousse; Toru Takimoto
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation.

Authors:  Shannon D Whitman; Rebecca Ellis Dutch
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

6.  Differential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation.

Authors:  Shannon D Whitman; Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

7.  Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity.

Authors:  Joanna Rawling; Blanca García-Barreno; José A Melero
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  Stimulation of Nipah Fusion: Small Intradomain Changes Trigger Extensive Interdomain Rearrangements.

Authors:  Priyanka Dutta; Ahnaf Siddiqui; Mohsen Botlani; Sameer Varma
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

9.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Authors:  Irina V Alymova; Garry Taylor; Toru Takimoto; Tsu-Hsing Lin; Pooran Chand; Y Sudhakara Babu; Chenghong Li; Xiaoping Xiong; Allen Portner
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.